Parliamentary activity

Answering body: Cabinet Office

Today, I have laid the Government Response to the public consultation on proposed changes to the Infected Blood Compensation Scheme. I have also published the accompanying report by the Technical Expert Group.

We consulted on seven specific areas of the compensation scheme and gave respondents an opportunity to tell us what else they thought should be changed. I am pleased that we are now making substantial changes in all seven areas, and making an additional change based on feedback we heard. These changes will increase the levels of compensation available for infected and affected people.

I am grateful to the Infected Blood Inquiry, and would like to pay tribute to Sir Brian Langstaff and his team for the sensitivity and care with which they carried out their work. The Government has now fully responded to all of the Inquiry’s Additional Report recommendations on the design of the compensation scheme.

Answering body: Cabinet Office

On 9 July 2025 the Infected Blood Inquiry published its Additional Report on Compensation. The Inquiry made a number of recommendations to the Cabinet Office and to the Infected Blood Compensation Authority (IBCA) to ensure that fair compensation is provided to every person that is eligible without delay.

As of 21 October, IBCA has contacted over 3,614 people to start their compensation claim, and 3,371 have started the claim process. 2,476 people have received an offer, totalling over £1.8 billion, and so far 2,033 people have had their compensation paid with more than £1.35 billion paid in compensation by IBCA. IBCA has now contacted all registered infected people to begin a claim, and the Government expects IBCA to open the service for those who are infected and unregistered, deceased infected and affected this year.

I am pleased that progress is being made, but I acknowledge the calls from the community highlighting the need for faster payment. That is why, on 21 July 2025, I informed the House that the Government would make a further interim payment of £210,000 to the estates of infected persons who were registered with an Infected Blood Support Scheme or predecessor scheme (on or before 17 April 2024) and have sadly passed away.

This is in addition to the interim payment of £100,000 which opened for applications in October 2024, meaning an estate could be eligible for up to £310,000 in interim payments. Since applications opened, over 600 estates have received payment, totalling over £60 million.

Today, I can announce that the process under which estates can apply for a further interim compensation payment has now opened. I hope this payment goes some way in recognising the hurt of those who have been impacted by losing their loved ones due to infected blood and blood products.

These payments will be delivered through the existing Infected Blood Support Schemes. They will be made to the estates of deceased infected persons As with all compensation payments related to infected blood, it will be exempt from income tax, capital gains tax and inheritance tax and disregarded from means tested benefit assessments.

Only the personal representative of the estate is able to make the application. Applicants will need a grant of probate, letters of administration, or a grant of confirmation (specific to Scotland) to evidence entitlement to claim interim compensation on behalf of the estate. To assist the legal process of obtaining this evidence as quickly as possible (for those that do not already have it), applicants can claim back their exact legal costs up to £1,500. The application form is available to download online at gov.uk, together with full guidance on how to apply.

For those estates that have already received £100,000 an expedited application form is available. This requires much less information from the applicant than provided previously. Estate representatives can access this directly by contacting the UK Infected Blood Support Schemes.

I hope this additional interim payment brings some relief to the families impacted by a scandal that is a shameful mark on our national history. Please rest assured that delivering compensation for every person that is eligible remains an utmost priority for this Government.

Answering body: Cabinet Office

On 21st July, I updated the House that the Government would be bringing forward further regulations to respond to the recommendations of the Infected Blood Inquiry’s Additional Report. I also informed the House that to make the proposed changes to the Infected Blood Compensation Scheme would require further technical clinical and legal advice. I can now confirm that this advice will be provided by a new Infected Blood Compensation Scheme Technical Expert Group.

The Technical Expert Group will assist the Government in developing proposals, in response to the Inquiry’s Additional Report, for public consultation. Following that consultation, the Government will be in a position to finalise any changes to the Infected Blood Compensation Scheme, informed by the consultation findings and the Technical Expert Group’s advice.

I have published the Terms of Reference for the Technical Expert Group, including full membership, as well as its work programme. To ensure the necessary changes to the compensation scheme can be implemented with the minimum possible delay to IBCA’s ongoing delivery of compensation, I am appointing all members of the previous Expert Group to the new group. In addition, I am pleased to have personally appointed five further experts to broaden the group’s expertise and ensure any changes to the scheme are thoroughly assessed and validated. The new additional members to the Technical Expert Group are as follows:

Dr Lise Estcourt, Transfusion Medicine specialist

Dr Susie Shapiro, Haematology Specialist

Dr Chloe Beale, Psychological medicine - psychiatrist

Professor Deborah Christie, Psychological medicine - psychologist

Professor John Weinman, Psychological medicine - psychologist

The appointments I have made reflect feedback from infected blood community stakeholders and I thank the community representatives for their valuable input into this process.

While the previous Expert Group, appointed by my predecessor, provided advice which enabled the Government to take critical decisions on the design of the Infected Blood Compensation Scheme, I acknowledge the Inquiry’s and community’s criticisms about the transparency of its work.

After reflecting on the Inquiry’s report, I gave the House an undertaking that transparency will be at the heart of any expert group going forward. Today I published an open letter to Professor Sir Jonathan Montgomery, who I have asked to Chair the new Technical Expert Group, setting out my expectations on how it will operate. This includes an expectation that the group will undertake targeted engagement with the infected blood community on issues raised in the Inquiry’s Additional Report, to inform its work and help it answer the questions set out in its work programme.

Answering body: Cabinet Office

Today, the Infected Blood Inquiry has published an Additional Report. This additional report reflects the unprecedented nature of the Infected Blood Scandal and the thoroughness of the Inquiry’s investigation. I am grateful to Sir Brian Langstaff and the dedicated work of the Inquiry.

I would like to reiterate a wholehearted and unequivocal apology on behalf of current and previous governments to every single person impacted by this scandal. Nothing of this nature can ever happen again, but for this to be anything more than words, more tangible action must be taken.

The UK Government committed £11.8bn in the Budget, delivered on 30 October 2024, for the Infected Blood Compensation Scheme. As of 1 July, 460 people have received their compensation payment, totalling £326,184,985.78. 2,043 people have begun their compensation claim and 616 people have received an offer of compensation, totalling £488,346,336.18.

The Government is committed to reflecting carefully on this Report to ensure that people who are both infected and affected are properly supported in their search for justice for this devastating Scandal and to receive compensation they are due.

As the Inquiry notes “it is the time now to build constructively on the scheme as it is and as it operates”. During the hearings to the Infected Blood Inquiry, I set out that there were matters that the Government is willing to consider in light of any recommendations from the Inquiry. The Inquiry has today made a total of nine recommendations many of which reflect the areas I have already committed to reviewing. These include eligibility for the unethical research award; the 31 March 2025 cut-off date, beyond which people will not be able to register with support schemes as a bereaved partner; expanding the supplementary route for the affected; the position of persons infected with HIV before 1 January 1982 and the Special Category Mechanism (and its equivalents).

The Government will now quickly work through these recommendations and work closely with the Infected Blood Compensation Authority to understand the delivery implications of any policy changes to the Scheme.

In his concluding remarks, Sir Brian Langstaff has said “it is fair to record that the Government has taken major steps”. It is our firm commitment, as we reflect on the Inquiry’s work, to continue to take steps and support the Infected Blood Compensation Authority to deliver compensation to victims of this scandal as quickly as possible.

Subject to parliamentary approval, my intention is to provide a further update to the House before summer recess, and a response to Sir Brian’s Additional Report of actions the Government is taking in due course.

Answering body: Cabinet Office

Yesterday, the Infected Blood Inquiry set out its intention to publish an additional report. The Inquiry also published a number of witness statements, including ones provided by the Cabinet Office, the Infected Blood Compensation Authority and a number of people directly impacted by the Infected Blood scandal and their representatives.

The victims of the Infected Blood scandal have suffered unspeakably and their needs continue to remain at the forefront of our work. The Government will give careful consideration to the statements published by the Inquiry. I am committed to continuing to build trust with people who are impacted by this scandal, and to engage further with representatives of the infected blood community on the Government’s response. We will continue to cooperate with the Inquiry over the coming months.

The Government is determined to deliver justice for people who are infected and affected as a result of the Infected Blood Scandal. That is why, in the Autumn Budget, we set aside £11.8 billion to compensate victims of the Infected Blood scandal. This is one of the biggest compensation schemes in our country’s history - and that is entirely right given the scale of this injustice. In line with our commitment, in December last year the Infected Blood Compensation Authority began delivering this compensation. As of Friday 21 February, 204 people have been invited to start their claim, and IBCA is on track to meet its commitment for 250 people to start their claim by the end of March.

Before the end of March, both Houses will have the opportunity to debate the draft regulations for people who are affected including partners, parents, children, siblings and, in some instances, carers. Once in force, the draft Infected Blood Compensation Scheme Regulations 2025 will provide IBCA with the powers it needs to begin making payments to eligible affected people. We have committed that payments to affected people will start by the end of 2025.

The Government also recognises that delivering justice is much more than financial compensation. I am continuing to work with the Department of Health and Social Care, taking forward the Inquiry’s recommendations to ensure that everything is done to prevent further such tragedies in the future.

My personal commitment to this work, and the people impacted by it, remains steadfast. The Government is acting on the findings of the Inquiry. We will continue to work with the Infected Blood Compensation Authority to ensure compensation is delivered as swiftly and compassionately as possible to everyone who so greatly deserves it.

Answering body: Cabinet Office

The Infected Blood Inquiry’s final report was published on 20 May 2024 and made 12 recommendations. The recommendations made by Sir Brian Langstaff are wide-ranging, well considered, and necessarily complex.

In the months since the publication of the Inquiry’s report, Parliament has come together a number of times to discuss the infected blood scandal. In the course of those debates, I committed to providing an update on the Government’s response to the recommendations by the end of this year. This update fulfils that commitment. Alongside this statement, I am publishing a command paper detailing the full update on gov.uk, and I have requested that copies be deposited in the libraries of the Houses of Parliament.

The Government accepts in full or accepts in principle all of the recommendations made. Where recommendations are accepted in principle, we have sought to explain the rationale for doing so. Many of the recommendations are wide-reaching, and proper implementation needs time to be delivered effectively. The Government has worked to progress implementation and assess the deliverability of each of the recommendations. We are committed to making meaningful change. As per Recommendation 12 of the Infected Blood Inquiry, I will provide a further final update on the progress made on Inquiry's recommendations by May 2025.

I am grateful to my ministerial colleagues for their co-operation, and in particular my hon. Friend the Parliamentary Under-Secretary of State for Public Health and Prevention at the Department of Health and Social Care for his leadership on the recommendations for which his department is responsible. I am also grateful to Ministers in the devolved governments, in particular the Minister for Public Health and Women's Health in Scotland, the Cabinet Secretary for Health and Social Care in Wales and the Minister of Health in Northern Ireland. Their engagement has been invaluable in ensuring that we have as consistent an approach as possible across the whole United Kingdom.

The victims of this scandal have suffered immeasurably. It is my utmost intention to deliver what justice and compensation the Government can as quickly as possible. This government is taking concrete action to deliver on the compensation scheme. The Chancellor announced £11.8bn of funding in the Autumn Budget, and I am pleased to update that the Infected Blood Compensation Authority has been able to make the first payments to the victims of this scandal in the last few days.

Furthermore, I can also confirm today that the Government has also extended its eligibility criteria for siblings for the Infected Blood Compensation Scheme to ensure that the Scheme provides fair compensation to those who have been devastatingly impacted as a result of their sibling’s infection.

Under the new definition, siblings of infected people will be eligible if they, while under the age of 18, lived in the same household as an infected person for a period of at least 2 years after the onset of the infection, or would have been expected to live in the same household were it not for the impact of the infection. Siblings in this scenario will receive an Injury Impact Award in line with the severity of the infection, and a Social Impact award of £12,000.

Alternatively, siblings will also be eligible as long as they cohabited, or were expected to cohabit with the infected person were it not for the impact of the infection, for at least 2 years whilst the affected sibling was under the age of 18. This is the case even if that period was prior to the infection, including if the infection happened during adulthood. Siblings in this scenario will receive an Injury Impact Award in line with the severity of the infection, and a Social Impact Award of £8,000. This mirrors the Social Impact Award available to carers, parents (where the onset of a child’s infection began after age 18); and children (where the onset of a parent’s infection began after their child turned 18).

I hope that both these updates provide the infected blood community with some assurance that we are learning from and acting on the mistakes of the past.

Answering body: Cabinet Office

In May, the Infected Blood Inquiry produced its final report and the country heard the full extent to which thousands of men, women, and children had their lives overturned by the use of infected blood and blood products in the NHS. The infected blood scandal is a shameful mark on our national history. I would like to pay tribute to the courage and determination of every single person that has suffered because of the use of infected blood and to those who have taken tireless action to ensure their community is heard. Every death that results from the infected blood scandal is a tragedy, and this Government is committed to acting on the findings of the Infected Blood Inquiry to ensure swift resolution for all of those impacted.

The principal recommendation from the Infected Blood Inquiry was that the Government compensation scheme for victims of infected blood should be established ‘now’. The Infected Blood Compensation Scheme was legally established for people who are infected and claiming compensation through the Core Route in regulations laid on 23 August. We expect the Infected Blood Compensation Authority to begin making payments to people who are infected by the end of this year, and last week the Infected Blood Compensation Authority reached out to the very first claimants under the Scheme. However there is still more to do. Subject to Parliamentary approval, the Government is aiming for a second set of regulations to be in force by 31 March 2025. This will support our shared aim to begin payments to people who are affected in 2025.

The Government also recognises that people have waited far too long for compensation payments. That’s why interim payments are crucial for supporting people until the Infected Blood Compensation Authority is up and running. In October 2022, interim payments of £100,000 were made to living infected beneficiaries or bereaved partners registered with the Infected Blood Support Schemes. In June this year, further interim payments of £210,000 were made to living infected victims of infected blood. Through these interim payments, over £1 billion has been paid to people who are infected or their bereaved partners.

The Victims and Prisoners Act 2024 placed a statutory duty on the Government to deliver interim payments of £100,000 to estates for deaths not yet recognised through financial compensation. This followed the recommendation in Sir Robert Francis’ Compensation Framework Study that interim payments should be made to “to recognise the deaths of people to date unrecognised and thereby alleviate immediate suffering” and achieves the spirit of recommendation 12 of the Infected Blood Inquiry’s Second Interim Report in the most practicable way.

On 26 July, I informed the House that the applications for interim payments due to be made to estates of deceased infected persons were scheduled to open in October, and that further details were to follow. Today, I can announce that the process under which estates can apply for interim compensation payments has now opened. For many people, this is the first substantial compensation payment they will benefit from to recognise the lives of people they have lost as a result of the use of infected blood and blood products.

This is a £100,000 interim payment, and as with any compensation payment related to infected blood, it will be exempt from income tax, capital gains tax and inheritance tax and disregarded from means tested benefit assessments.

As with the previous interim payments, these payments will be delivered through the existing Infected Blood Support Schemes. These payments are to be made to the estates of deceased infected persons, where interim payments have not already been received, in those cases where the deceased infected person was registered with an existing or predecessor scheme on or before 17 April 2024.

Those who were not registered with an existing or predecessor scheme on or before this date may still be eligible for compensation. For these cases, estate representatives will need to apply to claim compensation with the Infected Blood Compensation Authority, once applications open. I will provide a further update on this in due course.

Where an interim compensation payment has already been made directly to the infected person, to their bereaved partner, or their estate, an estate will be ineligible for this interim payment.

Only the personal representative of the estate is able to make the application. Applicants will need a grant of probate, letters of administration, or a grant of confirmation (specific to Scotland) to evidence entitlement to claim interim compensation on behalf of the estate. To assist the legal process of obtaining this evidence as quickly as possible (for those that do not already have it), applicants can claim back their exact legal costs up to £1,500.

The application form is available to download online at gov.uk, together with full guidance on how to apply. Applicants may request a hard copy of the application form from the UK Infected Blood Support Scheme operating in the nation of the UK where the deceased infected person was infected. The completed form and supporting documents should be sent to the relevant Infected Blood Support Scheme.

Answering body: Cabinet Office

I should like to inform the House that I have appointed three interim Non-Executive Board Members to the Infected Blood Compensation Authority under Part 3 of the Victims and Prisoners Act 2024:

Russell Frith, appointed as an Interim Audit and Risk Board Member, effective from 1st October 2024 until 1 October 2025;

Deborah Harris-Ugbomah, appointed as an Interim Commercial Board Member, effective from 1st October 2024 until 1 October 2025; and

Paula Sussex, appointed as an Interim Digital and Data Board Member, effective from 1st October 2024 until 1 October 2025.

Sir Robert Francis KC, the interim Chair of the Infected Blood Compensation Authority, has also appointed three interim Non-Executive Board Members:

Sir Robert Behrens, appointed as an Interim Community Engagement Board Member, effective from 1st October 2024 until 1 October 2025;

Helen Parker, appointed as an Interim Community Engagement Board Member, effective from 1st October 2024 until 1 October 2025; and

Gillian Fairfield, appointed as an Interim Medical Board Member, effective from 1st October 2024 until 1 October 2025.

These short term appointments will support the Infected Blood Compensation Authority to deliver compensation to people who are infected and affected in a timely manner. An open and fair recruitment process will commence in 2025 to fill these posts substantively.

The Government is absolutely committed to acting on the findings of the Infected Blood Inquiry and today’s announcement is progress towards that collective aim. I will continue to update the House as we progress work to deliver long overdue compensation to people infected and affected as a result of the Infected Blood Scandal.

Answering body: Cabinet Office

Today, Sir Brian Langstaff has published the final report of the independent Infected Blood Inquiry. I am authorising a copy of the report to be deposited in the Libraries of both Houses.

I am very grateful to Sir Brian for his forensic and detailed report, his team’s diligent work over the six years of the Inquiry, and for the sensitivity and care with which he has ensured that the people directly and indirectly impacted by the infected blood scandal have been front and centre of his Inquiry’s work. His report is a very substantial document, and it will be impossible for anyone reading it not to be deeply affected by its content. The report lays bare the devastating consequences of the use of infected blood and blood products, and I hope it answers the questions that the infected and affected have been asking for so long.

I have listened to the strongly held views of those members of the infected blood community that I have spoken with; this day is about the truth, the community, and a time for reflection about those they have lost, and the suffering which they have endured over decades.

It is right that the Government should formally recognise this significant report on the day of publication, and so the Prime Minister will give a short statement to Parliament later today. There will be a further statement tomorrow in the Commons regarding compensation.

The Government will look to provide the House with a further opportunity to debate the Infected Blood Inquiry's final report.

Answering body: Cabinet Office

On 18 December 2023 I updated the House that the Government would appoint a group of clinical, legal and social care experts to advise the Cabinet Office on detailed technical considerations of responding to the Infected Blood Inquiry’s recommendations on compensation.

Further to my December update, I am today pleased to announce the appointment of Professor Sir Jonathan Montgomery as Chair of this expert group. Sir Jonathan will lead the expert group to provide me, the responsible Minister for the Government's response to the Infected Blood Inquiry, technical advice on compensation.

Both my Right Honourable Friend Earl Howe GBE and I have met separately with Sir Jonathan to discuss the technical advice the expert group will provide and are reassured that the group is working as quickly as possible to advise the Government in responding to the Inquiry’s recommendations following the publication of the final report.

Sir Jonathan is an experienced healthcare law scholar who has played a leading role in UK public bioethics for many years, having previously chaired the Human Genetics Commission (2009-2012), the Nuffield Council on Bioethics (2012-2017) and the Health Research Authority (2012-2019). Sir Jonathan is currently the Chair of the Oxford University Hospitals NHS Foundation Trust and Professor of Healthcare Law at University College London. Sir Jonathan received a knighthood in 2019 for his services to bioethics and Healthcare Law.

Ensuring the victims of the infected blood scandal receive the justice and recognition they deserve remains my top priority and I look forward to working with Sir Jonathan and the expert advisory group to ensure that the Government has the relevant expertise to make informed choices in responding to the inquiry’s recommendations on compensation.

Answering body: Cabinet Office

The Infected Blood Inquiry Chair has announced that the Inquiry’s final report has been delayed from Autumn 2023 and will now be published in March 2024. I recognise the calls for urgency from those who have suffered and continue to suffer, and I remain committed to responding to the Inquiry as quickly as the Government is able to do so. However, it is only reasonable that the Government’s response is fully informed by Sir Brian’s final report.

I am aware that for some the Inquiry, as well as the ongoing parliamentary and public interest in this important issue, has meant reliving painful memories and feelings of loss and grief. I have been deeply moved to hear of the suffering and trauma that each individual has encountered as a result of this tragedy.

The timetable of the Inquiry is a matter for the independent Chair and the Government supports his desire to complete the Inquiry’s vital work quickly but with the necessary thoroughness. The Government continues to fully support the Inquiry in its important work and is working hard to be ready to respond.

I will update Parliament as soon as it is appropriate.

Answering body: Cabinet Office

The Infected Blood Inquiry has heard first hand details of the terrible suffering experienced by the victims of infected blood over many years, and the urgent need to address the financial uncertainty faced by many.

This Government commissioned Sir Robert Francis QC to produce an independent study with options for a workable and fair framework of compensation for those infected and affected by the tragedy. A copy of Sir Robert’s report is in the Library of this House.

Following Sir Robert’s detailed evidence given to the Inquiry in July, the Chair of the Infected Blood Inquiry, Sir Brian Langstaff delivered an interim report to the government. In accordance with section 26 of the Inquiries Act 2005, a copy of Sir Brian’s interim report has been laid before Parliament. In his report, Sir Brian made the following recommendations:

“(1) An interim payment should be paid, without delay, to all those infected and all bereaved partners currently registered on UK infected blood support schemes, and those who register between now and the inception of any future scheme;

(2) The amount should be no less than £100,000, as recommended by Sir Robert Francis QC.”

On 16 August, I wrote to Sir Brian to confirm that the government has accepted his recommendation in full and that we will be making an interim payment of £100,000, by the end of October, to all infected beneficiaries and bereaved partners registered with the four national support schemes. The date of effect of the recommendation is 29 July 2022, the date that Sir Brian delivered his report. Any infected person or bereaved partner registered with one of the four schemes operating in England, Scotland, Wales or Northern Ireland on that date will be eligible to receive the payments. Sir Brian’s recommendation - which this government accepts - was careful not to exclude any eligible person who, for whatever reason, may have not registered themselves with their relevant national support scheme. Should they do so in future, before the inception of any future scheme, they will also be eligible for such a payment, subject to successful application to the scheme.

The intention is that payments will be tax-free and will not affect any financial benefits support an individual is receiving. In advance of the payments, the four support schemes will write to beneficiaries, confirming tax exemptions and benefit disregards, and provide practical details about how the payments will be made. The UK Government will provide the funding to ensure that those eligible, wherever they are living in the United Kingdom, will receive the payment.

As recognised by Sir Robert Francis and Sir Brian Langstaff, this group of victims is the immediate priority for the government because we recognise that, tragically, many of these individuals will not see the conclusion of the Inquiry.

However, I am mindful that there will be people deeply affected by this tragedy who will not benefit from these payments. Sir Robert’s detailed Compensation Framework Study makes carefully considered recommendations about the further scope of compensation, including that carers and bereaved relatives (a cohort of affected people not currently supported by financial support schemes) should be compensated. In his interim report, Sir Brian makes specific reference to bereaved parents and children but notes the complexities in determining the approach to their compensation.

To those individuals and others who are out of scope of these payments, I would like to emphasise that the interim payments the government has announced are the start of the process and not the end. Sir Robert’s study has been warmly welcomed by the Inquiry and, without prejudging the findings of the independent Inquiry, I fully expect his wider recommendations to inform the Inquiry’s final report when it is published in mid-2023. Until that time, the government will continue work in consideration of the broader recommendations in the Compensation Framework Study so that we are ready to respond promptly when the Inquiry concludes its work.

Answering body: Cabinet Office

Today the Government is publishing the study by Sir Robert Francis QC, which was commissioned by my predecessor as Paymaster General, the Rt Hon Penny Mordaunt MP.

The study makes recommendations for a framework for compensation and redress for the victims of infected blood, which can be ready to implement upon the conclusion of the Infected Blood Inquiry, should the Inquiry’s findings and recommendations require it.

Sir Robert’s study is comprehensive and detailed, and reflects the contributions of many individuals directly affected by infected blood, their recognised legal representatives, and campaign groups representing the infected and affected communities, many of whom participated in a series of meetings held by the study from July 2021 to February 2022. Sir Robert makes clear the importance of these contributions by introducing his study with a collection of moving, heartbreaking and sometimes shocking quotations from some of those who spoke to him. It is right that their views and experiences should be at the heart of his work, and I would like once again to thank all those who contributed to the study and shared their experiences with Sir Robert. I do not underestimate how difficult this must have been for many, and I am grateful for their courage.

Sir Robert will give evidence about his work to the Infected Blood Inquiry on 11th and 12th July. Before then, it is important that the Inquiry, and recognised legal representatives of its infected and affected core participants, have an opportunity to consider his work; it is most important that the government is able to reflect upon Sir Robert’s evidence to the Inquiry in considering his study.

There is a great deal of complexity to the issues that the study covers and a wide range of factors to be taken into account in considering Sir Robert’s recommendations. This analysis cannot be completed hurriedly but officials across government are focussing on this so that the government can be ready to respond quickly to the Inquiry’s recommendations, as was intended when the study was commissioned. I will update the House as this work progresses.

I would like, once again, to thank Sir Robert and his team for their work and the timely delivery of the study.

I have asked that a copy of the Study be deposited in the libraries of both Houses in Parliament.

Answering body: Cabinet Office

On 20 May 2021, the Government announced the appointment of Sir Robert Francis QC, to carry out a study to look at options for a framework for compensation for people infected and affected by infected blood, and it was agreed that the study would report back to the Government before the independent Infected Blood Inquiry reports.

I am pleased to confirm that Sir Robert delivered his report to me on 14 March. Sir Robert completed the comprehensive and detailed study in a timely fashion, and I would like to thank Sir Robert and his team for the careful and sensitive way they have worked. I would also like to thank all those who contributed to the study, sharing their experiences and views with Sir Robert. I know this must have been very difficult for many. I am grateful for their valuable contributions.

I will now carefully consider Sir Robert’s findings and recommendations. It is my intention to publish the Study and the Government response, in time for the Inquiry and its core participants to consider them before Sir Robert gives evidence to the Inquiry. I will write in due course to Sir Brian Langstaff, the Chair of the Inquiry, about our plans for responding and publication.

Answering body: Cabinet Office

On 20 May my predecessor, my Right Honourable friend, the member for Portsmouth North, announced the appointment of Sir Robert Francis QC to carry out an independent study to look at options for a framework for compensation for victims of infected blood. The study will make recommendations for compensation, before the Infected Blood Inquiry reports. Terms of Reference of the study were to be finalised following consultation between Sir Robert and those infected and affected. The consultation period concluded in August, and Sir Robert wrote to my predecessor with his recommendations.

Sir Robert’s consultation received a positive response from the infected and affected community. 447 formal responses were submitted (including from many of the legal representatives of infected and affected core participants of the Inquiry), along with over 150 further representations, primarily personal accounts from the infected and affected on how this tragedy has affected their lives. These accounts were of great assistance to Sir Robert in reviewing the draft Terms of Reference. Sir Robert wishes to express his gratitude to the many individuals who contributed to the consultation, in many cases having to relive the awful experiences they have suffered over so many years, and I would like to echo his gratitude.

Sir Robert’s recommendations identify the key issues that the study should consider. They offer assurance to the infected and affected communities that the matters of most concern to them will be considered by the Study. I am therefore happy to accept Sir Robert’s recommendations in full, and I am today publishing the following Terms of Reference without amendment:

RATIONALE FOR COMPENSATION

● To consider the rationale for compensation as a matter of general principle and in relation to any particular classes of compensation, recognising that it is not for the Study to pre-empt the determination by the Infected Blood Inquiry as to what, if any, rationale is supported by the evidence it has received;

INDEPENDENT ADVICE TO GOVERNMENT

● Give independent advice to the Government regarding the design of a workable and fair framework for compensation for individuals infected and affected across the UK to achieve parity between those eligible for compensation regardless of where in the UK the relevant treatment occurred or place of residence. While the Study is to take into account differences in current practice and/or law in the devolved administrations, it is not asked to consider whether delivery of that framework should be managed centrally or individually by the devolved administrations;

SCOPE OF COMPENSATION

● To consider the scope of eligibility for such compensation (including the appropriateness or otherwise of any conditions such as ‘cut-off’ dates), and whether it should be extended beyond infected individuals and their partners, to include for example affected parents and children, the wider affected family (e.g. siblings), and significant non-family carers and others affected, either because of the impact of caring responsibilities or the effects of bereavement or some other impact; to include consideration of former and new partnerships/marriages; and whether the estate of any individual who has died should be eligible for compensation;

CATEGORIES OF INJURY AND LOSS

● To consider the injuries, loss and detriments that compensation should address, in relation to the past, present and future, including:

(a) the physical impact and consequences of infection/s (including the effect of any treatment, and potential future adverse effects);

(b) infections that cleared naturally; and the risk of any significant or long-term side effects of treatment (such as liver damage, increased risk of cancer) even if they are yet to materialise;

(c) the mental health, social and financial impacts (including access to financial services) - both actual and in terms of loss of opportunities - suffered by both the infected and affected; and

(d) other types of loss if appropriate;

TYPES OF AWARD AND METHOD OF ASSESSMENT

● To consider: (a) the extent to which any framework should offer compensation on the basis of an individualised assessment and/or fixed sums or a combination of these (including consideration of the position of an individual who was both infected, and affected by another individual’s infection);

(b) whether awards should be by way of final lump sums, periodical payments or both;

(c) whether an individual should be required to prove matters (if so what types of matters, by what means, and to what standard);

(d) whether there should be any limitation by way of time or other bar on entitlement or claim, and whether any existing time bars should be maintained;

(e) the extent to which compensation should be limited to matters currently recognised by the law (taking into account any differences in the law across the UK) on damages and evidence as recoverable for the purposes of compensation, or, if not, the basis on which broader matters should be taken into account;

MEASURES FOR COMPENSATION

● To consider the measures for compensation, looking at other national schemes (for example, the compensation tribunal established in the Republic of Ireland) to examine their merits or otherwise, and experiences, both as to form (i.e. administration/process) and the substance of compensation;

RELATIONSHIP WITH CURRENT SCHEMES

● To consider the relationship between a compensation framework and other receipts and payments by individuals, including: (a) the pre-existing financial support schemes; (b) legal claims; (c) welfare benefits and tax;

OPTIONS FOR ADMINISTERING THE SCHEME

● To consider options for administering the scheme (including but not limited to what bodies, organisations or tribunals might need to be established to facilitate such administration); what principles, aims or criteria etc might underpin the development of an appropriate scheme; and any ancillary matters which should be considered such as interim payments, publicity of the scheme, outreach to potential claimants, and support;

OTHER ISSUES

● To consider other issues that, in the course of his investigations, Sir Robert considers relevant; and

REPORTING TO GOVERNMENT BY FEBRUARY 2022

● To Submit to the Government its report and recommendations as quickly as possible and no later than the end of February 2022, to provide the Government with advice on potential options for compensation framework design.

-----

Sir Robert and his team will now begin the more detailed conversations and analysis to look into the detail of the issues raised by the infected and affected community. This will allow him to produce a set of comprehensive recommendations to the complex issues involved.

I, like my predecessor, am deeply committed to ensuring that Sir Brian Langstaff’s independent public inquiry has all the resources it needs to complete its work; in Sir Brian’s words, “as quickly as thoroughness permits”. The infected blood scandal continues to claim the lives of infected people, and those directly affected have waited too long for answers, and for justice.

Answering body: Department of Health and Social Care

Today the Government has announced its intention to increase the financial support for beneficiaries of the infected blood support scheme in England, administered by the NHS Business Services Authority (NHSBSA).

This follows a meeting on 21 January 2019 between myself, the Chancellor of the Duchy of Lancaster, the Infected Blood Inquiry secretariat and affected beneficiaries where I committed to looking at where further improvements might be made to the support provided by the existing infected blood scheme.

In this announcement, we have set out our plans for a major uplift in the financial support available to infected and affected beneficiaries of the infected blood support scheme in England. The current annual cost of the scheme is estimated at £46.3m per annum and we expect this will increase to over £75m to provide for these uplifted payments.

The level of support provided to infected beneficiaries will increase. In addition, the upper threshold level of household income currently used to means-test support provided for the bereaved will also be substantially raised allowing more bereaved beneficiaries to be eligible for additional support from the scheme.

All beneficiaries will be sent a letter by NHSBSA this week setting out the details of the changes and the impact they will have on them. This detailed payment information will also be made available on NHSBSA’s website. All new payments will be backdated to 1 April 2019.

I have also announced my intention to reach out to the devolved administrations to look at how we might provide greater parity of support across the United Kingdom. I will update Hon. Members on these conversations in due course.

Today’s announcement reconfirms the Government’s commitment to providing those affected by the infected blood tragedy of the 1970s and 1980s with a fair and transparent support scheme, one which focusses on their welfare and long-term independence.

It also reaffirms the Prime Minister’s support for the Infected Blood Inquiry, which she ordered in 2017, and which specifically asked for the support given to those affected by infected blood be looked at again. The Government will continue to listen to and co-operate fully with the Inquiry.

Answering body: Cabinet Office

On 24th September, I attended the commemoration that preceded the preliminary hearings of the Infected Blood Inquiry, and watched the moving and powerful testimony from those infected and affected by the infected blood scandal. The commemoration brought home the terrible human cost of this tragedy, and emphasised to me the importance of this Inquiry, to get to the truth of what happened, and provide the answers that the people infected and affected so desperately need.

When the public Inquiry was launched in July this year, I deferred making a decision on whether to appoint a panel to sit with Sir Brian until he was able to take the view of core participants. Sir Brian Langstaff wrote to me this week following the preliminary hearings, and has advised me that he has now done so, and there has been no demand for a panel. In the place of single experts, sitting as panellists, Sir Brian is establishing expert groups to provide openness and transparency across a range of truly expert opinion. He recommended that I should not appoint co-determining panel members. I accept his recommendation.

In his letter Sir Brian also called for action in relation to financial and psychological support for the affected and infected. The Government will consider those comments and Sir Brian’s recommendations carefully and will respond as soon as possible.

The Cabinet Office takes seriously its role as sponsor to the Infected Blood Inquiry and is determined to do all it can to support the Inquiry with its work. Regrettably, an administrative error earlier this year has come to light, which had delayed the circulation of an instruction to government departments about the retention of records. I can reassure the public that this has resulted in no actual harm, but it is an error for which I apologise to the Inquiry, and most importantly, to the people infected and affected.

The facts are these: Cabinet Office official circulated a Government-wide notice on 3rd April this year, instructing departments to preserve all information relevant to the Infected Blood Inquiry. A further, more comprehensive message was issued to departments by Cabinet Office on 11th June.

However, following a query from the Inquiry about the notice, Cabinet Office officials discovered that the 3rd April email containing the retention notice did not reach its recipients, due to the failure of the collective IT address used. My officials have provided a detailed explanation to the Inquiry which will be published on the Inquiry’s website.

Since the error was discovered, all relevant departments and relevant areas within departments have worked urgently to confirm that they have not destroyed any documents relevant to the Inquiry during the period between 3rd April and 11th June. Because of their size and the complexity of some of the records they hold, HM Courts and Tribunals Service and the Legal Aid Agency are continuing to work to provide this assurance and have committed to doing so as urgently as possible.

The Department of Health and Social Care put in place a moratorium on the destruction of historical records as soon as the Inquiry was announced in July 2017. No material damage has resulted from this administrative error, but I am very sorry it occurred, and I would like to reassure the public that the Cabinet Office will learn the lessons from this to avoid such an error occurring in future.

Answering body: Cabinet Office

I am announcing today the appointment of Sir Brian Langstaff to head the public inquiry into the Infected Blood scandal. The inquiry will be established under the 2005 Inquiries Act, with full powers, including the power to compel the ​production of documents, and to summon witnesses to give evidence on oath.

In relation to the appointment of the Chair, the Lord Chief Justice was asked to recommend a judge who, in his view, would be best suited to the task. The Lord Chief Justice recommended Sir Brian Langstaff: a highly respected and hugely experienced High Court judge. I have accepted the Lord Chief Justice’s recommendation.

Sir Brian will be the full time Chair of the Inquiry from 1 May following his retirement from the High Court. However, in order that those who have been affected by this tragedy face no further undue delay, he will use the intervening period to conduct a further consultation on the Inquiry’s Terms of Reference

The infected blood scandal of the ’70s and ’80s was an appalling tragedy that should never have happened. The victims of this tragedy who have endured so much pain and hardship deserve answers. It is crucial that their views are properly reflected in the Inquiry’s Terms of Reference. He will want to listen carefully to the voices of those that have suffered before making a recommendation to me on what the scope of the Inquiry should be. I will return to Parliament with the final terms of reference as soon as this process has been completed.

The Government will ensure that the inquiry has the resources that it needs to complete its work. The Inquiry will, of course, also be independent of the Government.

It is very important that the Inquiry can identify why and how this tragedy occurred and provide answers for the all victims who have suffered so terribly, and can identify lessons to be learned so that a tragedy of this scale can never happen again.

Answering body: Prime Minister

As the Government announced last month, a full statutory inquiry into the infected blood scandal will be established under the 2005 Inquiries Act, and sponsored by the Cabinet Office. The inquiry will have full powers, including the power to compel the ​production of documents, and to summon witnesses to give evidence on oath.

We are today setting out the next steps.

The Cabinet Office has now completed its analysis of the responses to the consultation on the format of the statutory Inquiry into infected blood announced in July. In addition a series of roundtable meetings were held earlier this month with individuals and groups representing those affected.

The Government committed to making an announcement regarding the Chair of the inquiry before Christmas, taking into account the views we have received. We are therefore announcing today our intention to appoint a judge to Chair the inquiry. We will make a further statement on who that judge will be in the New Year and we will be discussing with them the composition of the Inquiry panel.

We would like to thank each and every person who took the time to respond to the consultation, and to share their views and experiences. We understand how difficult these issues must have been to describe and we are grateful for the frankness and honesty with which people have shared their experiences. The responses to the consultation have been carefully considered by Cabinet Office officials. We can assure the House and everyone who contributed that the findings will be passed to the proposed Chair to help inform the discussions regarding the draft Terms of Reference, on which we expect there will be further consultation.

In accordance with the Inquiries Act 2005, colleagues in the Devolved Administrations will be consulted as the Terms of Reference are finalised.

A further statement will be made in the New Year.

Answering body: Cabinet Office

On 11 July 2017, the Prime Minister announced that a full, independent public inquiry would be held into the contaminated blood scandal of the 1970s and 1980s, and promised to work with the victims and families of those affected by this tragedy in order to decide what form the inquiry should take. Since then, we have been listening to views from the affected community and have received over 800 written responses to the consultation, which closed on 18 October.

I am keen for the inquiry to proceed as quickly as possible in order to provide those affected with the answers they deserve. Taking into account the views of those who responded to the consultation, I am announcing today that responsibility for setting up the independent inquiry will transfer from the Department of Health to the Cabinet Office with immediate effect. I am also announcing that this will be a full statutory public inquiry, created under the 2005 Inquiries Act.

The Cabinet Office has now taken receipt of all the response to the consultation, which it will analyse thoroughly. This work will be completed as quickly as possible, and a further announcement will follow before the end of the year on the setting up of the inquiry.